Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03833180
Title A Phase 1 Dose-Escalation and Cohort-Expansion of VLS-101 in Hematologic Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors VelosBio Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope ( Site 0010) Duarte California 91010 United States Details
University of California - San Diego ( Site 0003) La Jolla California 92093 United States Details
UCLA Hematology & Oncology ( Site 0007) Los Angeles California 90095 United States Details
University of Nebraska Medical Center ( Site 0006) Omaha Nebraska 68198-5331 United States Details
Northwell Health ( Site 0009) New Hyde Park New York 11042 United States Details
Weill Cornell Medical College ( Site 0005) New York New York 10021 United States Details
Memorial Sloan Kettering Cancer Center ( Site 0014) New York New York 10065 United States Details
University of Rochester ( Site 0008) Rochester New York 14642 United States Details
Memorial Sloan-Kettering Cancer Center ( Site 0019) Uniondale New York 11553 United States Details
Oregon Health & Science University ( Site 0004) Portland Oregon 97239 United States Details
MD Anderson Cancer Center ( Site 0001) Houston Texas 77030 United States Details
MD Anderson Cancer Center ( Site 0011) Houston Texas 77030 United States Details
University of Virginia Cancer Center ( Site 0012) Charlottesville Virginia 22908 United States Details
Swedish Medical Center ( Site 0002) Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field